Cancer is a leading cause of disease burden in Australia, particularly fatal burden, accounting for an estimated thirty percent of deaths. Many cancers develop because of exposure to lifestyle and environmental factors that are potentially modifiable. We aimed to quantify the proportions and numbers of cancer deaths and cases in Australia in 2013 attributable to 20 modifiable factors in eight broad groupings that are established causes of cancer, namely: tobacco smoke (smoking and secondhand), dietary factors (low intake of fruit, non-starchy vegetables and dietary fibre; and high intake of red and processed meat), overweight/obesity, alcohol, physical inactivity, solar ultraviolet radiation, infections (seven agents), and reproductive factors (lack of breastfeeding, menopausal hormone therapy use, combined oral contraceptive use). We estimated population attributable fractions (PAF) using standard formulae incorporating exposure prevalence and relative risk data. Of all cancer deaths in Australia in 2013, approximately 38% overall (males 41%, females 34%) could be attributed to the factors assessed; the corresponding PAF for cancer cases was 33% (males 34%, females 32%). Tobacco smoke was the leading cause of cancer deaths and cases, with PAFs of 23 and 13%, respectively, followed by dietary factors (5% deaths/5% cases), overweight/obesity (5%/4%) and infections (5%/3%). Cancer sites with the highest numbers of potentially preventable deaths/ cases were lung (n 5 6,776/9,272), colorectum (n 5 1,974/7,380) and cutaneous melanoma (n 5 1,390/7,918). We estimate that about 16,700 cancer deaths and 41,200 cancer cases could be prevented in Australia each year if people's exposures to 20 causal factors were aligned with levels recommended to minimise cancer risk.
Because different types of cancer differ considerably in their case fatality rates, the preventable fraction of cancer deaths will differ from the preventable fraction of cancer cases diagnosed. Therefore, our present aim was to estimate the number and proportion of cancer deaths in Australia in 2013 that were attributable to modifiable causal factors. In doing so, we also updated our previous estimates of the attributable number and proportion of cancers diagnosed in Australia using 2013 incidence data and the most recent assessments of causality.
Methods
For most causal factors (hereafter referred to as "factors"), we calculated the PAF using relative risks and the prevalence of the factor in the population of interest. Factors for which the calculation method deviates from this approach [tobacco smoke, solar UV radiation, infections and use of the combined oral contraceptive pill (OCP)] are discussed below in Statistical Analyses.
We used the standard formula 6 to calculate the PAF by age and sex category:
Where p x is the proportion of the population in factor level x and ERR x the excess relative risk (RR x -1) associated with factor level x. The PAF is expressed as a percentage and is an estimate of the proportion of deaths/cases that would be prevented if exposure to the factor in the population were reduced to the level of the reference category (as described in Table 1 ).
We considered the same lifestyle and environmental factors as we included in our analyses of cancer incidence attributable to modifiable causes in Australia in 2010 (Australian PAF Incidence Study). 7 To be included, the factors had to meet the following three criteria: (i) evidence of a causal association between the factor and at least one cancer, as determined by either the World Cancer Research Fund (WCRF) or the International Agency for Research on Cancer (IARC); (ii) Australian prevalence data for the factor were available and (iii) exposure to the factor is potentially modifiable. 7 The factors that met these criteria are summarised in Table 1 .
Both the WCRF and IARC continually reassess their causality assessments in light of new data. 5 Since our previous assessment in 2014, additional cancers have been newly determined as causally associated with body mass index (BMI; stomach-cardia, 8 liver, 9 advanced/fatal prostate, 10 thyroid, 11 multiple myeloma 11 ), alcohol consumption (stomach 8 ) and processed meat (stomach 8 ). In contrast, the level of evidence has been revised downwards from "probable" to "limited" for associations between fruit and non-starchy vegetable intake and cancers of the oesophagus and stomach. 8, 12 We therefore updated our estimates of the number and proportion of cancers diagnosed in Australia associated with these factors to enable comparison with our new estimates of PAF for mortality.
Cancer data
We sourced cancer incidence and mortality data from the Australian Institute of Health and Welfare. 13 For many cancers, the number of deaths in any one year is small and prone to fluctuate from year to year. We therefore averaged the number of deaths from 2012 to 2014 (latest available) to estimate the average number of deaths in 2013. Incidence data at the histology level (adenocarcinomas and squamous cell carcinomas (SCC) of the oesophagus) and sub-site level (cardia and non-cardia stomach cancers) were not available for 2013. To estimate the numbers of these cancers diagnosed in 2013 we applied the average age-, sex-and histology/subsite specific incidence rates between 2010 and 2012 (latest available) to the 2013 Australian estimated resident population. As cancer deaths are not coded at the histology level, we also applied the proportional distribution of histologyspecific incidence to the number of oesophageal cancer deaths (by age and sex) to estimate the histology-specific mortality in 2013 (i.e., assuming the distribution of deaths by histology for these sites is similar to the distribution of new diagnoses).
For cancers with only a small number of deaths (viz., vulva, vagina, penis, lip, salivary glands and the pharyngeal cancers) data were only available on the total deaths in 2012 14 and 2014. 2 To estimate the number of deaths for each of these cancers by age and sex in 2013, we applied the distribution of the incident cancers by age and sex (averaged from 2011 to 2013) to the number of deaths (averaged for 2012 and 2014) for each cancer.
What's new?
Cancer is the leading cause of death in Australia. Yet many of these deaths could be prevented if known causes were avoided. In this study, the authors estimated the number and fraction of cancer deaths and cancer cases in Australia attributable to modifiable factors. They found that 38% of all cancer deaths and 33% of cancer cases could be attributed to 20 factors. Tobacco smoke was the leading cause of cancer death, followed by dietary factors, overweight/obesity, infections and solar ultraviolet radiation. 2 The 2010 Australian PAF Incidence Study also included oesophagus (squamous cell carcinoma) and stomach cancer. WCRF no longer considers that there is strong evidence for an association between consumption of fruit and non-starchy vegetables and these cancers. 3 WCRF declares strong evidence for association between processed meat and cancer of the stomach (non-cardia). Not included here as separate prevalence estimate for processed meat not available for Australian population. 4 Numbers not calculated separately as HIV is not necessary or sufficient.
Relative risk estimates
For our primary analysis, we used summary relative risks obtained from recent high-quality meta-analyses of cancer incidence (see Supporting Information Tables S1-S9 ). We used relative risks for cancer incidence rather than cancer mortality because incidence data are far more complete and of higher quality. The one exception was the relative risk for overweight/obesity and prostate cancer, for which the causal association is restricted to advanced/fatal cancer, so we used the WCRF relative risks for prostate cancer mortality. Where possible we used relative risks reported in the most recent meta-analyses conducted by the WCRF that summarised prospective studies of incidence. For factors not summarised by the WCRF, we used recent high-quality meta-analyses or risk estimates from pooled or prospective studies of cancer incidence.
Exposure prevalence estimates
We used the same prevalence data as used in the Australian PAF Incidence Study (see Supporting Information Tables S10-S18). 7 The exceptions to this were prevalence estimates for human papillomarvirus (HPV; see below) and duration of combined OCP use (see Supporting Information Table S16 ).
Where possible we used population-based prevalence data from the National Health and Nutrition Surveys conducted by the Australian Bureau of Statistics. [15] [16] [17] [18] Prevalence of infectious agents such as viral hepatitis and the human immunodeficiency virus (HIV) were sourced from the "HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2012." 19 For other factors, we used "best estimates" of population prevalence from representative state-based surveys, population-based case-control studies or large-scale cohort studies. The selection of prevalence estimates requires assumptions to be made about the latent period between exposure to the factor and death from cancer/diagnosis of cancer. In this study, we used the latest cancer data available (average 2012-2014) combined with prevalence data from 1995 (dietary factors) or 2001. Hence, latent periods ranged from 12-18 years for most factors.
Statistical analysis
To obtain the number of cancer deaths/cases attributable to each factor, we summed the product of age-, sex-and cancer site-specific PAFs and the corresponding average number of observed (or estimated) deaths/cases in 2013.
A combined PAF across all factors for each cancer site and all cancer deaths/cases combined was also calculated using the following formula 20 :
Where PAF r is the PAF of each individual factor.
For each cancer site, we present the combined PAF and number of deaths/cases for all ages (0-851 years) and the combined PAF and number of deaths/cases that occurred prematurely, defined here as deaths before the age of 75 years. We present the total number of attributable cancer deaths (all sites combined) for the age groups 0-74 years and 751 years for each factor; these numbers are also expressed as a percentage of the number of all cancer deaths in these two age groups. We also compare the number and proportion of cancer deaths in 2013 to the updated results for cancer incidence for each factor.
Tobacco smoke. To estimate the PAF for tobacco smoke, we used the approach developed by Peto et al. 21 This method assumes tobacco smoking is the overwhelming cause of lung cancer mortality and incidence. The number of lung cancer deaths/cases attributable to smoking is the difference between the number of lung cancer deaths/cases observed in the population and the number expected if the entire population experienced the same age-and sex-specific lung cancer mortality and incidence rates as never smokers (see Supporting Information Table S19 ). From these estimates, a "notional prevalence" of smoking in the Australian population was derived and used to calculate the PAF for tobacco smoking for cancers other than lung using relative risks and standard formulae (see Supporting Information Table S20 ). To estimate the PAF for partners' smoking, we used the standard formula incorporating the proportion of non-smoking Australians living with an ever-smoking partner and relative risks associated with partner smoking (see Supporting Information  Tables S21 and S22) .
Solar UV radiation. The PAF for solar UV radiation was calculated as the proportional difference between the mortality/incidence from melanoma in Australian residents (i.e., "exposed" to high ambient UV radiation) and the expected number of melanoma deaths/cases assuming an ethnically similar population was "minimally exposed" to ambient UV radiation. We used the 1950-52 mortality data for England and Wales as the "minimally exposed" reference population, as this preceded the advent of mass tourism and solarium use 22 (see Supporting Information Table S23 ). For the updated PAF incidence estimates, we used melanoma incidence rates for the United Kingdom (2012-2014) as our "minimally exposed" population.
Infections. For cancers caused by infectious agents [such as HPV and Epstein-Barr virus (EBV)] for which no other causes are known, the PAF is assumed to equal the prevalence of viral DNA in tumour cells. 23 We used updated HPV prevalence estimates from international sources for cancers of the vulva, 24 vagina, 25 penis, 26 anus, 27 oral cavity 28 and oropharynx. 28 For oropharyngeal cancers, we used HPV prevalence estimates from a recently published Australian study (see Supporting information Table S24) . 29 For the association between Helicobacter pylori and non-cardia stomach cancer, we used updated relative risks that were based on improved assay procedures using immunoblot rather than ELISA 30 (see Supporting Information Table S25 ).
Combined oral contraceptive pill (OCP). The combined OCP reduces the risk of deaths from endometrial and ovarian cancer, but increases the risk of breast and cervical cancer mortality (Table 1) . For endometrial and ovarian cancers, we calculated the prevented fraction (PF) using the following formula:
Where P y is the proportion of the population in each age and "duration of combined OCP use" category y and RR y is the relative risk for each "duration of combined OCP use" category y compared to never users.
To estimate the total number of endometrial and ovarian cancer deaths/cases that would have occurred, but were prevented through use of combined OCPs, the following formula was used:
Where N x is the observed number of deaths/cases in each age category and PF x is the prevented fraction in each age category.
Results
In 2013, cancer was the cause of 44,004 deaths in Australia. We estimated that approximately 38% (n 5 16,739) of these deaths were attributable to 20 discrete, potentially modifiable causal factors across eight broad groupings [41% (n 5 10,232) males and 34% (n 5 6,507) females]. These percentages were higher when we considered only deaths in people aged 0-74 years: 43% of all deaths; 47% among males (5,746 deaths) and 38% among females (3,483 deaths; Table 2 ). Detailed results for each exposure are included in Supporting Information (Tables S26 to S38 ). Cancers of the uterine cervix and Kaposi's sarcoma had PAFs of 100% (227 and 2 deaths respectively at all ages), as the infectious agents [HPV and Kaposi's sarcoma herpes virus (KSHV), respectively] are considered necessary causal factors. Other cancer sites with very high mortality PAFs were cutaneous melanoma (90%), anus (86%), larynx (83%), lung (82%) and lip, oral cavity and pharynx (77%). The sites with the largest number of potentially preventable cancer deaths were lung (n 5 6,776), colorectum (n 5 1,974), cutaneous melanoma (n 5 1,390), liver (n 5 1,052) and stomach (n 5 898; Table 2 ).
Tobacco smoke was the leading cause of cancer death in 2013 with a PAF of 23% (26% males and 18% females; 9,921 cancer deaths). This was followed by dietary factors (PAF 5 5%, 2,329 cancer deaths), overweight/obesity (5%, 1,990) and infections (5%, 1,981; Fig. 1 ).
While only 15 cancer deaths in 2013 could be attributed to the use of combined OCPs, we estimated that 159 endometrial cancer deaths and 294 ovarian cancer deaths were prevented in 2013 because women had used the combined OCP (Table 3) .
In the updated incidence analysis, the overall PAF (0-851 years) was essentially unchanged from our previously reported overall estimate (33%; males 34% and females 32%), 5 despite some changes in relative risk estimates arising from newer data. The PAFs were similar in people age 0-74 years (Table 4 ). Cancer sites with the largest number of potentially preventable cancers were lung (n 5 9,272), cutaneous melanoma (n 5 7,918), colorectum (n 5 7,380) and breast (n 5 3,609; Table 4 ). Figure 1 shows the updated PAFs for incidence for each factor; the main changes were a decrease for diet (from 6.1% to 5.4%) and an increase in overweight/ obesity (from 3.4% to 4.3%) due to changes in cancers included. There was an increase in the PAF for infections only for men (from 2.4 to 3.0%) due to the use of updated relative risks and prevalence data for cancers that are more common in men than women (oropharynx and stomach). Changes were also seen in the prevented fraction for oral contraceptive use and ovarian cancer because we updated our estimates of the prevalence of combined OCP use by duration in 2013. This resulted in an increase in the prevented fraction from 19 to 25%. A similar increase was not seen for endometrial cancer because we also updated the relative risk to that reported from a more recent pooled analysis of prospective studies 32 and this change offset the effect of changing the prevalence. For many factors, the cancer mortality PAFs were similar to those estimated for cancer incidence (Fig. 1) . The main exceptions were tobacco smoke and solar UV radiation. For smoking, the PAF for cancer mortality was around two-thirds higher than for cancer incidence (23 vs. 13%); for solar UV radiation, the cancer mortality PAF was half that for incidence (3 vs. 6%).
When we stratified by age group (0-74 years vs. 751 years), tobacco smoke accounted for the greatest proportion of cancer deaths in both younger (30% males and 20% females) and older persons (22% males, 17% females; Table  5 ). For males aged 0-74 years, dietary factors (7%), overweight/obesity (6%) and infections and alcohol (both 5%) were the next greatest contributors to premature cancer deaths, whereas dietary factors (5%), overweight/obesity (4%) and solar UV radiation (4%) were the next greatest contributors to avoidable cancer deaths among the older group (Table  4) . Of note, markedly fewer cancer deaths in males were attributable to alcohol (<2%) among those aged 751 years compared with those 0-74 years (5%; Table 5 ). For females, tobacco smoke was the leading cause of cancer death, followed by infectious agents, dietary factors, and overweight/ obesity, although the rank order of these factors differed between younger and older women (Table 5) . Potentially modifiable factors considered: tobacco smoke (smoking and smoking by partner), alcohol consumption, overweight/obesity, dietary factors (low intake of fruit, non-starchy vegetables and dietary fibre, high intake of red and processed meat), insufficient physical activity, lack of breastfeeding, menopausal hormone therapy use, combined oral contraceptive use, infections (seven agents) and solar ultraviolet radiation.
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Discussion
An estimated 38% of cancer deaths and 33% of cancer cases (all ages) in Australia in 2013 were attributable to 20 discrete, modifiable causal factors across eight broad groupings. This proportion was higher for deaths occurring below the age of 75 years (persons 43%; males 47%; females 38%). The leading preventable cause of cancer death in Australia was tobacco smoke, accounting for around half of the estimated preventable deaths from cancer. Dietary factors, overweight/obesity, infections (seven agents) and solar UV radiation were also important contributors. Although arbitrary, we selected 75 years as the cut-off for "premature death" on the basis that the level of general frailty and presence of co-morbidities is higher in people over 75 years making it difficult to disentangle contributory causes of death. 33, 34 The same cut-off has been used previously by studies of avoidable mortality in Australia 34 and the United Kingdom. 33 PAF estimates for other national studies of cancer mortality range from 35% in France 35 to 60% in the United States 36 (see Supporting Information Table S39 ). Differences in the Cancer Epidemiology Potentially modifiable factors considered: tobacco smoke (smoking and smoking by partner), alcohol consumption, overweight/obesity, dietary factors (low intake of fruit, non-starchy vegetables and dietary fibre, high intake of red and processed meat), insufficient physical activity, lack of breastfeeding, menopausal hormone therapy use, combined oral contraceptive use, infections (seven agents) and solar ultraviolet radiation.
PAFs for some of the factors can be explained by differences in exposure prevalence between countries. For example, the PAFs for cancer mortality associated with overweight/obesity are much lower for China (0.3%) 37 and Japan (1%) 38 than for Australia (5%) 39 and the United States (5-15%). 36 Conversely, the cancer mortality PAFs for infections are higher in the Asian countries (29% and 22% in China and Japan respectively, vs. 5% in Australia), where prevalence of hepatitis B and Helicobacter pylori, in particular, is high. 38 Differences in PAFs between countries are also due to inclusion of different sets of risk factors, the cancer sites considered causally associated with those risk factors, the choice of relative risks and differences in analytic methods.
Although different methods and outcomes are used, we note that the Australian Burden of Disease Study estimated that the joint effect of selected modifiable risk factors contributed 44% of the total cancer burden (fatal and non-fatal) in Australia in 2011. 40 Using Disability Adjusted Life-Years (DALYs) as the measure, tobacco contributed 22% of the total cancer burden, followed by high body mass (7%), dietary risk factors (7%), physical inactivity (6%) and sun exposure (5%). 40 The proportion of cancer deaths attributable to potentially modifiable factors was higher than that for cancer diagnoses (38% compared to 33%). Other studies that have published PAFs for both mortality and incidence have also reported higher PAFs for mortality (Brazil: PAF mortality 42% vs. PAF incidence 34% 41 ; Japan: 46 vs. 43% 38 ). In our study, this difference appears to be mostly due to PAFs for tobacco smoke (23% for mortality vs. 13% for incidence). Smokingrelated cancers generally have high mortality, in particular lung cancer remains the leading cause of cancer death in both males and females with a 5-year relative survival at diagnosis of only 16% (14% males and 19% females). 2 We estimated that two-thirds of the tobacco-attributable cancer deaths were deaths from lung cancer.
Our study has a number of strengths. We followed the most recent judgements on causality from IARC and the WCRF, international agencies that have a continuous process for systematically reviewing the evidence. For the majority of factors, we were able to use prevalence data from surveys with nationally representative samples and high response rates 15, 17, 18 or, where these were not available, populationbased studies with large samples. 42 For our calculations of PAF mortality, we used relative risks for cancer incidence in preference to relative risks for cancer mortality. We did this for several reasons. There are more studies with cancer incidence as an outcome, and large prospective cohorts generally have many incident cancer cases over a 5-10 year follow-up period making their estimates more precise; in contrast, cancer mortality studies require very long follow-up periods to record a sufficient number of cancer deaths for analysis. In addition, the quality of data is often better for cancer diagnosis than for cause of death, especially for registration of histological subtypes. Data Cancer Epidemiology on cancer deaths relies on the specificity and completeness of the underlying causes of death listed on the death certificate. Notwithstanding the above, our approach assumes equivalence between the relative risks for incidence and mortality; that is, that the factor does not have an appreciable influence on survival after diagnosis. This assumption may not hold true for all of the factor-cancer couplets that were considered. To explore the potential impact of using relative risks for cancer incidence, we performed a sensitivity analysis using relative risks from prospective cohort studies (CPS II, CPS II Nutrition Cohort and Million Women Study) that had published effect estimates for both mortality and incidence for BMI-cancer associations [43] [44] [45] [46] [47] [48] [49] (see Supporting Information Table S40 ). We found that this assumption held true for most, but not all, cancer sites. There was no clear explanation for the discrepancies between the relative risks for incidence and mortality, as these occurred in cancers with quite different patterns of incidence, survival and mortality (pancreas, colorectum and multiple myeloma; see Supporting Information Table S41 ).
We acknowledge some limitations of this study. Our list of causal factors was restricted due to the availability of appropriate prevalence data. For example, we could not consider other factors that have been associated with cancer risk including ionising radiation, air pollution, coffee intake (protective), glycaemic load and processed meat (separate to red meat). We also did not include occupational exposures because an estimate of the future cancer incidence burden of Australians of working age in 2012 has been recently published; the proportion estimated was 1.4%. 50 The PAFs are sensitive to both the selection of prevalence data and the relative risks used in the calculations. We used the same prevalence estimates as used in the Australian PAF Incidence Study; the limitations of these data have been outlined in detail elsewhere. 5 In particular, nationally representative data on hormone use by type, duration of use and age group were not available, and there was only limited Australian data on exposure to infectious agents. 5 The accuracy of data on cancer deaths relies on the specificity of information on the death certificate. In particular, the Australian Bureau of Statistics has noted there is a high likelihood that there may be under-counting of the number of colorectal cancer deaths due to the frequent use of the broader term "bowel cancer" on death certificates, and the consequent coding of these deaths to the International Classification of Diseases code C26.0 (Malignant neoplasm: Intestinal tract, part unspecified) in accordance with the World Health Organisation internationally agreed rule set. 51 As several factors considered in our analysis (tobacco, alcohol, overweight/obesity, low intake of dietary fibre, high intake of red and processed meat, physical inactivity) are causally associated with cancers of the colon and rectum, our overall PAF may have been underestimated. For deaths due to cancers of the cervix and endometrium, all deaths coded as "uterusunspecified" (ICD-10 code C55) were considered endometrial cancer deaths, although a proportion of deaths allocated this code were likely to be caused by cervical rather than endometrial cancer. 52 This misallocation will not have affected the overall proportion of deaths attributable to causal factors, but sensitivity analysis suggested that we may have modestly underestimated the number of deaths from cervical cancer and conversely, modestly over-estimated the number of deaths from endometrial cancer.
PAFs are not static and should be recalculated at regular intervals to reflect both changing prevalence in exposures and the most up-to-date findings of cancer risk assessments and causal associations. For example, trends in the prevalence of exposure to tobacco smoke (declining) and obesity (increasing) in Australia, as well as the introduction of the HPV vaccine and new treatments for HIV and Hepatitis C, will all likely result in large changes in in future cancer incidence and mortality. Finally, we note that some modifiable causes of cancer act in synergy with other factors to markedly increase risks among people exposed. Such interactions were not explored in this analysis.
Conclusions
Cancers remain the leading cause of death in Australia, and we have shown that a large proportion of cancer cases in addition to deaths from cancer are, in theory, preventable. Tobacco smoke was the leading cause of avoidable cancer death, followed by dietary factors, overweight/obesity, infections and solar UV radiation. Even modest reductions in population exposure to known causes of cancer would likely translate to sizable reductions in premature deaths from cancer.
